Splitting irritable bowel syndrome: From original Rome to Rome II criteria

American Journal of Gastroenterology

Volumn 99, Issue 1, 2004, Pages 122-130

  Mearin, Fermin ^a   Roset, Montse ^b   Badía, Xavier ^b   Balboa, Agustin ^b   Baró, Eva ^b   Ponce, Julio ^b   Diaz Rubio, Manuel ^b   Caldwell, Ellen ^b   Cucala, Mercedes ^b   Fueyo, Arturo ^b   Talley, Nicholas J ^b  

^a CENTRO MÉDICO TEKNON   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONSTIPATION; DIARRHEA; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RESOURCE ALLOCATION; WELLBEING; ADOLESCENT; CLASSIFICATION; HEALTH STATUS; MIDDLE AGED; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGED; FEMALE; HEALTH STATUS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; QUALITY OF LIFE; SOCIOECONOMIC FACTORS;

EID: 1542388319     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1572-0241.2003.04024.x     Document Type: Article

References (40)

1. Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109:1736-41.
2. Thompson WG, Longstreth G, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II. The functional gastrointestinal disorders (2nd ed.). McLean, VA: Degnon Associates, 2000;351-432.
3. Kruis W, Thieme C, Weinzierl M, et al. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984;87:1-7.
4. American Gastroenterological Association. American Gastroenterological Association Medical Position Statement: Irritable Bowel Syndrome. Gastroenterology 1997;112:2118-19.
5. Manning AP, Thompson WG, Heaton KW, et al. Towards a positive diagnosis of the irritable bowel. BMJ 1978;2:653-54.
6. Talley NJ, Zinsmeister AR, Van Dyke C, et al. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927-34.
7. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
8. Drossman DA, Thompson WG, Talley NJ, et al. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int 1990;3:159-72.
9. Kay L, Jorgensen T. Re-defining abdominal syndromes: Results from a population-based study. Scand J Gastroenterol 1996;31:469-75.
10. Thompson WG, Dotevall G, Drossman DA, et al. Irritable bowel syndrome: Guidelines for the diagnosis. Gastroenterol Int 1989;2:92-95.
11. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45 (Suppl 2):II43-II47.
12. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.
13. Agreus L, Talley NJ, Svärdsudd, et al. Identifiying dyspepsia and irritable bowel syndrome: The value of pain and discomfort, and bowel habit descriptors. Scand J Gastroenterol 2000;35:142-51.
14. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: Are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000;95:3176-83.
15. Mearin F, Badía X, Balboa A, et al. Irritable Bowel Syndrome prevalence varies enormously depending on the employed diagnostic criteria: Comparisons of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;36:1155-61.
16. Instituto Nacional de Estadística. España en cifras. Madrid: INE, 1998.
17. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: Results from the medical outcomes study. JAMA 1989;262:907-13.
18. Alonso J, Regidor E, Barrio G, et al. Valores poblacionales de referencia de la versión española del Cuestionario de Salud SF-36. Med Clin (Barc) 1998;111:410-16.
19. Drossman DA. The functional GI disorders and the Rome II process. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II. The functional gastrointestinal disorders (2nd ed.). McLean, VA: Degnon Associates, 2000:1-30.
20. Talley NJ, Zinsmeister AR, Melton LJ III. Irritable bowel syndrome in a community: Symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995;142:76-83.
21. Heaton KW, O'Donnell LJ, Braddon FE, et al. Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters. Gastroenterology 1992;102:1962-67.
22. Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: Prevalence, incidence, natural history and risk factors. J Intern Med 1994;236:23-30.
23. Gaburri M, Bassotti G, Bacci G, et al. Functional gut disorders and health care seeking behavior in an Italian non-patient population. Recenti Prog Med 1989;80:241-44.
24. Schlemper RJ, van der Werf SD, Vandenbroucke JP, et al. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan. Scand J Gastroenterol Suppl 1993;200:33-41.
25. Caballero-Plasencia AM, Sofos-Kontoyannis S, Valenzuela-Barranco M, et al. Irritable bowel syndrome in patients with dyspepsia: A community-based study in southern Europe. Eur J Gastroenterol Hepatol 1999;11:517-22.
26. Jones R. Likely impacts of recruitment site and methodology on characteristics of enrolled patient population: irritable bowel syndrome clinical trial design. Am J Med 1999;107:85S-90S.
27. Agreus L. The epidemiology of functional gastrointestinal disorders. Eur J Surg 1998;583 (Suppl 1):60-66.
28. Sperber AD, Safieh YA, Jaffer AA, et al. A comparison of the prevalence of IBS using Rome I and Rome II criteria in an epidemiological survey (abstract). Gastroenterology 2000;118:397.
29. Thompson WG. The road to Rome. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II. The functional gastrointestinal disorders (2nd ed.). McLean, VA: Degnon Associates, 2000:629-35.
30. Okamoto K, Ohsuka K, Shiraishi T, et al. Comparability of epidemiological information between self- and interviewer-administered questionnaires. J Clin Epidemiol 2002;55:505-11.
31. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999;45 (Suppl 2):II1-II5.
32. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-8.
33. Smith RC, Greenbaum DS, Vancouver JB, et al. Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology 1990;28:293-301.
34. Whitehead WE, Bosmajian L, Zonderman AB, et al. Symptoms of psychologic distress associated with irritable bowel syndrome. Gastroenterology 1988;95:709-14.
35. Hahn BA, Kirchdoerfer LJ, Fullerton S, et al. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997;11:553-59.
36. Whitehead WE, Burnett CK, Cook EW, et al. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996;41:2248-53.
37. O'Keefe E, Talley NJ, Zinsmeister AR, et al. Bowel disorders impair functional status and quality of life in the elderly. A population based study. J Gerentol Med Sci 1995;50A: M184-M189.
38. Jones RH. Clinical economics review-Gastrointestinal disease in primary care. Aliment Phamacol Ther 1999;10:233-39.
39. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000;95:67-71.
40. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: A population based study. Gut 1997;41:394-98.